Valuation: Biogen Inc.

Market Cap 37.16B 33.86B 31.34B 28.35B 53.19B 3,471B 55.67B 379B 150B 1,876B 139B 137B 5,941B P/E 2026 *
50.8x
P/E 2027 * 22.6x
Enterprise Value 42.8B 38.99B 36.1B 32.65B 61.25B 3,997B 64.11B 436B 173B 2,160B 161B 157B 6,842B EV / Sales 2026 *
4.04x
EV / Sales 2027 * 3.73x
Free-Float
85.94%
Yield 2026 *
-
Yield 2027 * -
1 day-1.60%
1 week-1.02%
Current month-2.24%
1 month+6.19%
3 months+11.90%
6 months+30.11%
Current year+40.88%
1 week 243.58
Extreme 243.58
255.42
1 month 235.96
Extreme 235.955
261
Current year 160.36
Extreme 160.3645
261
1 year 160.36
Extreme 160.3645
261
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Exercice

Chief Technology Officer

1,735 0.0012%
2/10/26 Exercice

Controller/Auditor

62 0.0000%
1/9/26 Free

General Counsel

7,405 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%-1.02%+47.64%+7.74% 37.16B
-2.18%-5.14%+29.00%+126.56% 1,232B
-2.23%-5.75%+31.95%+78.25% 656B
-1.01%-3.81%+21.61%+104.79% 506B
-1.04%-1.80%+28.69%+68.33% 382B
-3.92%-9.70%+39.60%+29.23% 340B
-3.22%-5.20%+24.48%+50.97% 294B
-2.51%-4.49%-2.15%+31.64% 278B
-1.00%-5.80%+28.50%+65.81% 240B
-1.28%-0.32%+30.73%+120.29% 210B
Average -1.99%-2.15%+28.00%+68.36% 417B
Weighted average by Cap. -2.07%-2.66%+27.23%+86.56%

Financials

2026 *2027 *
Net sales 10.58B 9.64B 8.93B 8.07B 15.15B 988B 15.85B 108B 42.8B 534B 39.71B 38.87B 1,692B 10.78B 9.82B 9.09B 8.22B 15.42B 1,006B 16.14B 110B 43.58B 544B 40.43B 39.58B 1,723B
Net income 768M 700M 648M 586M 1.1B 71.71B 1.15B 7.83B 3.11B 38.75B 2.88B 2.82B 123B 1.78B 1.62B 1.5B 1.36B 2.55B 167B 2.67B 18.18B 7.21B 90B 6.69B 6.55B 285B
Net Debt 5.63B 5.13B 4.75B 4.3B 8.06B 526B 8.44B 57.44B 22.79B 284B 21.14B 20.7B 901B 3.08B 2.81B 2.6B 2.35B 4.41B 288B 4.62B 31.41B 12.46B 155B 11.56B 11.32B 493B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
20/11/26 US$247.41 -1.59% 559,315
18/11/26 US$251.41 +0.25% 1,144,901
17/11/26 US$250.79 -0.34% 969,020
16/11/26 US$251.65 -0.69% 839,762
13/11/26 US$253.40 +1.17% 1,028,943
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
251.41USD
Average target price
268.26USD
Spread / Average Target
+6.70%
  1. Stock Market
  2. Stocks
  3. BIIB Stock